Abstract LB-216: NCI 9455: Phase II study of trametinib followed by trametinib plus AKT inhibitor,GSK2141795 in patients with advanced triple negative breast cancer
Bhuvaneswari Ramaswamy(The Ohio State University), William E. Carson(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Mahmoud Abdel‐Rasoul(The Ohio State University), Robert Wesolowski(The Ohio State University Wexner Medical Center), Cynthia Timmers(Cancer Genetics (United States)), Miguel A. Villalona(Cancer Institute of Florida), Ewa Mrózek(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Erin Macrae(McGill University), Charles L. Shapiro(Tisch Hospital), Helen Chen(IQVIA (United States)), Rachel M. Layman(The University of Texas MD Anderson Cancer Center), Claudine Isaacs(Georgetown University), Andrew Poklepovic(Virginia Commonwealth University), Claire Dees(University of North Carolina at Chapel Hill), Maryam B. Lustberg(Yale Cancer Center), Robyn Patrick(The Ohio State University), Thomas Budd(Cleveland Clinic), Micheal R. Grever(Ohio University), Roohi Ismail‐Khan(Moffitt Cancer Center), Jennifer Sexton(Ohio University), Lyndsay N. Harris(National Institutes of Health)
Cited by 15
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
|New England Journal of Medicine|2012|1k